Key result
Higher on-treatment SBP linked to ~15% lower likelihood of successful drug withdrawal per 10 mmHg.
Why the study?
What baseline clinical characteristics predict the maintenance of normotension 12 months after withdrawal of antihypertensive drugs in elderly patients in general practice?
Cohort (n=503)
Yes
What baseline clinical characteristics predict the maintenance of normotension 12 months after withdrawal of antihypertensive drugs in elderly patients in general practice?
In elderly patients with well-controlled uncomplicated hypertension on single-agent therapy and lower on-treatment systolic blood pressure (particularly those aged 65-74 years), a trial of antihypertensive drug withdrawal can maintain normotension at 12 months in over a third of patients, provided indefinite systematic blood pressure monitoring is maintained.
Answers are grounded in this paper and cite their sources.
Lower on-treatment SBP and monotherapy were associated with sustained normotension post-withdrawal; leaves open randomized confirmation before deprescribing in elderly hypertension.
OBJECTIVES: To identify simple long term predictors of maintenance of normotension after withdrawal of antihypertensive drugs in elderly patients in general practice. DESIGN: Prospective cohort study. SETTING: 169 general practices in Victoria, Australia. PARTICIPANTS: 503 patients aged 65-84 with treated hypertension who were withdrawn from all antihypertensive drugs and remained drug free and normotensive for an initial two week period; all were followed for a further 12 months. MAIN OUTCOME MEASURES: Relative likelihood of maintaining normotension 12 months after drug withdrawal; relative likelihood of early return to hypertension after drug withdrawal. RESULTS: The likelihood of remaining normotensive at 12 months was greater among younger patients (65-74 years), patients with lower "on-treatment" systolic blood pressure, patients on single agent treatment, and patients with a greater waist:hip ratio. The likelihood of return to hypertension was greatest for patients with higher "on-treatment" systolic blood pressure. CONCLUSIONS: Age, blood pressure control, and the number of antihypertensive drugs are important factors in the clinical decision to withdraw drug treatment. Because of consistent rates of return to antihypertensive treatment, all patients from whom such treatment is withdrawn should be monitored indefinitely to detect a recurrence of hypertension.
No takes yet. Share an insight, caveat, or question.
Mark Nelson (2002) conducted a cohort in Treated hypertension (n=503). On-treatment systolic blood pressure (per 10 mm Hg increase) after antihypertensive drug withdrawal vs. Return to hypertension group was evaluated on Maintenance of normotension 12 months after withdrawal of all antihypertensive drugs (RR 0.85, 95% CI 0.81 to 0.89, p=<0.001). Higher on-treatment systolic blood pressure reduced the likelihood of maintaining normotension at 12 months, while single-drug therapy increased it.
Synapse has enriched 10 related papers. Consider them for comparative context: